Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Lorvotuzumab mertansine is a conjugate consisting of the cytotoxic maytansinoid, currently being evaluated in clinical trials for the treatment of CD56+ solid tumors and multiple myeloma, selectively targets CD56 (also called neural cell adhesion molecule or NCAM)…